Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: iProceedings

Date Submitted: Dec 2, 2021
Open Peer Review Period: Dec 2, 2021 - Dec 3, 2021
Date Accepted: Dec 3, 2021
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

Evaluation of Patient-Initiated Direct Care Mobile Phone–Based Teledermatology During The COVID-19 Pandemic

Kaur J, Sharma P, Thami G, Sethi M, Kakar S

Evaluation of Patient-Initiated Direct Care Mobile Phone–Based Teledermatology During The COVID-19 Pandemic

iProc 2021;7(1):e35400

DOI: 10.2196/35400

PMID: 27759104

PMCID: 5069688

Evaluation of Patient-Initiated Direct-Care Mobile-Phone Based Teledermatology During COVID-19

  • Jasleen Kaur; 
  • Priyanka Sharma; 
  • G.P. Thami; 
  • Maninder Sethi; 
  • Shruti Kakar

ABSTRACT

Background:

With advances in telecommunication, especially smartphones, teledermatology services are now being directly demanded from the specialists by the patients themselves. This model is known as patient initiated, direct-care teledermatology. It has been pushed to the forefront due to the COVID-19 pandemic.

Objective:

The objectives of this study were to determine patient’s satisfaction and dermatologist’s confidence in making a diagnosis in direct-care mobile phone based teledermatology.

Methods:

Patients availing direct-care teledermatology services during Covid-19 at a tertiary care centre were subjected to a questionnaire within 5 days of the teleconsultation to assess patient’s satisfaction and preference of using this model during and beyond the current COVID-19 pandemic. For assessing dermatologists’ aspect, the teledermatologists rated their confidence in making the clinical diagnosis on a scale of 1 - 10 for every case.

Results:

Out of total of 437 participants, 419 (95.9%) were satisfied with this mode of teledermatology. An overwhelming majority of 428 (97.9%) felt safe consulting the dermatologist by teleconsultation and not having to visit hospital in this COVID pandemic. Two hundred and sixty nine (61.6%) agreed that they would be happy to use teledermatology service even beyond COVID pandemic. The dermatologists’ confidence score in making accurate diagnosis ranged from 3 to 10 with a mean of 9.20 ± 1.12.

Conclusions:

The high levels of patient satisfaction and dermatologists’ confidence scores indicate that direct-care mobile teledermatology may be a useful tool in providing dermatological services in appropriate settings and its use should be explored even beyond COVID pandemic.


 Citation

Please cite as:

Kaur J, Sharma P, Thami G, Sethi M, Kakar S

Evaluation of Patient-Initiated Direct Care Mobile Phone–Based Teledermatology During The COVID-19 Pandemic

iProc 2021;7(1):e35400

DOI: 10.2196/35400

PMID: 27759104

PMCID: 5069688

Per the author's request the PDF is not available.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.